Katie E. Archer
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 9
-
- Synthesis and pharmacology of benzodiazepine derivatives 5
- Click Chemistry and Applications 3
- Synthesis and Biological Evaluation 2
- Co-authors
- Erin K. Maloney (11 shared papers)Ravi Chari (11 shared papers)Michael L. Miller (11 shared papers)Alan Wilhelm (8 shared papers)Rajeeva Singh (5 shared papers)Nathan Fishkin (6 shared papers)Yelena Kovtun (4 shared papers)Luke Harris (4 shared papers)
- Journals
- Molecular Cancer Therapeutics (4 papers)ACS Medicinal Chemistry Letters (2 papers)Cancer Research (2 papers)Molecular Pharmaceutics (1 paper)Bioconjugate Chemistry (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Katie E. Archer
11 papers receiving 188 citations
Peers
Comparison fields: 5 of 37
- Radiology, Nuclear Medicine and Imaging 112
- Oncology 131
- Organic Chemistry 46
- Molecular Biology 96
- Hematology 12
Countries citing papers authored by Katie E. Archer
This map shows the geographic impact of Katie E. Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie E. Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie E. Archer more than expected).
Fields of papers citing papers by Katie E. Archer
This network shows the impact of papers produced by Katie E. Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie E. Archer. The network helps show where Katie E. Archer may publish in the future.
Co-authors
The 25 scholars most cited alongside Katie E. Archer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 75 | |
| 2 | 2019 | 41 | |
| 3 | 1995 | 36 | |
| 4 | 2019 | 23 | |
| 5 | 2019 | 12 | |
| 6 | 2019 | 11 | |
| 7 | 2019 | 5 | |
| 8 | 2009 | 5 | |
| 9 | 2016 | 1 | |
| 10 | 2013 | 1 | |
| 11 | 2017 | 1 | |
| 12 | 2013 | 0 |
About Katie E. Archer
Katie E. Archer is a scholar working on Oncology, Organic Chemistry, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 211 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Synthesis and pharmacology of benzodiazepine derivatives (5 papers), Cancer therapeutics and mechanisms (4 papers), Click Chemistry and Applications (3 papers), Synthesis and Biological Evaluation (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Ion channel regulation and function (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (112 citations), Oncology (131 citations), Organic Chemistry (46 citations), Molecular Biology (96 citations) and Hematology (12 citations). Katie E. Archer has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Erin K. Maloney, Ravi Chari, Michael L. Miller, Alan Wilhelm, Rajeeva Singh, Nathan Fishkin, Yelena Kovtun, Luke Harris, Thomas A. Keating and Wěi Li. Their work appears in journals such as Molecular Cancer Therapeutics, ACS Medicinal Chemistry Letters, Cancer Research, Molecular Pharmaceutics and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.